About Frontage Laboratories
Frontage Laboratories is a company based in Exton (United States) founded in 2001 was acquired by Tigermed in May 2014.. Frontage Laboratories has raised $10.24 million across 1 funding round from investors including Tigermed and Baird Capital. The company has 1,560 employees as of December 31, 2024. Frontage Laboratories has completed 7 acquisitions, including Acme Bioscience, BRI Biopharmaceutical Research and BioTranex. Frontage Laboratories offers products and services including Drug Discovery Services, Drug Development Services, and Laboratory Testing Services. Frontage Laboratories operates in a competitive market with competitors including Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Precision for Medicine, among others.
- Headquarter Exton, United States
- Employees 1560 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Frontage Holdings Corp.
-
Annual Revenue
$256.23 M (USD)-2.23as on Dec 31, 2024
-
Net Profit
$794.44 K (USD)-92.71as on Dec 31, 2024
-
EBITDA
$45.83 M (USD)-17.68as on Dec 31, 2024
-
Total Equity Funding
$10.24 M (USD)
in 1 rounds
-
Latest Funding Round
$10.24 M (USD), Series A
Apr 25, 2008
-
Investors
Tigermed
& 1 more
-
Employee Count
1560
as on Dec 31, 2024
-
Investments & Acquisitions
Acme Bioscience
& 6 more
-
Acquired by
Tigermed
(May 08, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Frontage Laboratories
Frontage Laboratories is a publicly listed company on the HKEX with ticker symbol 1521 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Frontage Laboratories
Frontage Laboratories offers a comprehensive portfolio of products and services, including Drug Discovery Services, Drug Development Services, and Laboratory Testing Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides end-to-end chemistry and biology for drug candidates
Supports preclinical and clinical trial processes
Offers bioanalytical and analytical testing for pharmaceuticals
Unlock access to complete
Unlock access to complete
Funding Insights of Frontage Laboratories
Frontage Laboratories has successfully raised a total of $10.24M through 1 strategic funding round. The most recent funding activity was a Series A round of $10.24 million completed in April 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $10.2M
-
First Round
First Round
(25 Apr 2008)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2008 | Amount | Series A - Frontage Laboratories | Valuation | Baird Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Frontage Laboratories
Frontage Laboratories has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Tigermed and Baird Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity and venture capital investments in B2B Tech & Services companies.
|
Founded Year | Domain | Location | |
|
Drug development and preclinical services are provided by Tigermed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Frontage Laboratories
Frontage Laboratories has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Acme Bioscience, BRI Biopharmaceutical Research and BioTranex. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
DMPK and analytical services are offered via hepatocyte-based platforms.
|
2009 | ||||
|
ADME and DMPK services are provided through mass spectrometry techniques.
|
2009 | ||||
|
Provider of a wide range of genomics services
|
2006 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Frontage Laboratories
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Frontage Laboratories Comparisons
Competitors of Frontage Laboratories
Frontage Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Precision for Medicine, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of drug discovery and preclinical development services
|
|
| domain | founded_year | HQ Location |
Data analysis and statistical solutions are provided for life sciences.
|
|
| domain | founded_year | HQ Location |
Provider of laboratory tests for physicians
|
|
| domain | founded_year | HQ Location |
Provider of clinical research, development, and commercialization services for life sciences
|
|
| domain | founded_year | HQ Location |
Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Frontage Laboratories
Frequently Asked Questions about Frontage Laboratories
When was Frontage Laboratories founded?
Frontage Laboratories was founded in 2001 and raised its 1st funding round 7 years after it was founded.
Where is Frontage Laboratories located?
Frontage Laboratories is headquartered in Exton, United States. It is registered at Exton, Pennsylvania, United States.
Is Frontage Laboratories a funded company?
Frontage Laboratories is a funded company, having raised a total of $10.24M across 1 funding round to date. The company's 1st funding round was a Series A of $10.24M, raised on Apr 25, 2008.
How many employees does Frontage Laboratories have?
As of Dec 31, 2024, the latest employee count at Frontage Laboratories is 1,560.
What is the annual revenue of Frontage Laboratories?
Annual revenue of Frontage Laboratories is $256.23M as on Dec 31, 2024.
What does Frontage Laboratories do?
Frontage Laboratories was established in 2001 in Exton, United States, operating as a contract research organization in the pharmaceutical and biotechnology sectors. Early-phase drug development services are delivered, encompassing bioanalytical laboratory operations, discovery-stage activities, preclinical metabolism and pharmacokinetics studies, phase IIIa clinical trials, and product development support. Organic synthesis, formulation development, GMP analytical testing, and clinical trial material manufacturing under GMP standards are also conducted for diverse drug candidates.
Who are the top competitors of Frontage Laboratories?
Frontage Laboratories's top competitors include LabCorp, Charles River Laboratories and Cytel.
What products or services does Frontage Laboratories offer?
Frontage Laboratories offers Drug Discovery Services, Drug Development Services, and Laboratory Testing Services.
Is Frontage Laboratories publicly traded?
Yes, Frontage Laboratories is publicly traded on HKEX under the ticker symbol 1521.
How many acquisitions has Frontage Laboratories made?
Frontage Laboratories has made 7 acquisitions, including Acme Bioscience, BRI Biopharmaceutical Research, and BioTranex.
Who are Frontage Laboratories's investors?
Frontage Laboratories has 2 investors. Key investors include Tigermed, and Baird Capital.
What is Frontage Laboratories's ticker symbol?
The ticker symbol of Frontage Laboratories is 1521 on HKEX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.